KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Other Non-Current Assets (2016 - 2026)

West Pharmaceutical Services has reported Other Non-Current Assets over the past 18 years, most recently at $81.3 million for Q1 2026.

  • Quarterly Other Non-Current Assets rose 15.81% to $81.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $81.3 million through Mar 2026, up 15.81% year-over-year, with the annual reading at $80.1 million for FY2025, 7.81% up from the prior year.
  • Other Non-Current Assets was $81.3 million for Q1 2026 at West Pharmaceutical Services, up from $80.1 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $81.3 million in Q1 2026 and troughed at $1.2 million in Q3 2022.
  • The 5-year median for Other Non-Current Assets is $49.4 million (2022), against an average of $50.4 million.
  • Biggest five-year swings in Other Non-Current Assets: tumbled 92.94% in 2022 and later surged 3133.33% in 2023.
  • Tracing WST's Other Non-Current Assets over 5 years: stood at $38.4 million in 2022, then plummeted by 44.53% to $21.3 million in 2023, then surged by 248.83% to $74.3 million in 2024, then grew by 7.81% to $80.1 million in 2025, then rose by 1.5% to $81.3 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $81.3 million, $80.1 million, and $75.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.